The US Food and Drug Administration (FDA) has posted a number of new or revised Product-Specific Drug Development Bioequivalence guidances. The Guidances cover a wide range of drugs and also complex products such as Metered Dose Inhalers (MDI). With over 2000 studies...
All
News
BioPharma Premises Found Safe “Above and Beyond”: Toronto Public Health Inspection
BioPharma Services Inc., since the early days of the COVID-19 or Coronavirus pandemic, has followed stringent safety guidelines recommended by public health departments in both Canada and the USA. Our premises were renovated and we operated with reduced in-house staff...
BioPharma Relocates To Expanded Clinic Facility in St. Louis, Missouri
BioPharma Services is excited to announce the relocation of their US based clinical trial facility to a new location in the city of St. Louis, Missouri.
BioPharma Services Identified As Essential Service Provider
BioPharma’s Canadian operations will continue to operate in accordance with public health guidelines to provide vital medical research and clinical trials.
A message from our chief executive officer Renzo Dicarlo
BioPharma Services Inc. has established a cross-functional COVID-19 taskforce with representation from senior leadership and experts across the company.
FDA Guidance on Conduct of Clinical Trials During COVID-19 Pandemic
The US Food and Drug Administration (FDA) has issued new guidance to ensure the safety of volunteers in clinical trials during the global COVID-19 pandemic.